Double Medical(SZ:002901) Sou Hu Cai Jing·2025-10-09 13:56Core Insights - The stock of Dabo Medical (002901) closed at 58.18 yuan on October 9, 2025, with a rise of 3.89% and a trading volume of 64,900 hands, resulting in a transaction amount of 379 million yuan [1] Group 1: Financial Performance - Dabo Medical reported a main business revenue of 1.21 billion yuan for the first half of 2025, an increase of 25.55% year-on-year [3] - The net profit attributable to shareholders was 244 million yuan, up 76.69% year-on-year [3] - The second quarter of 2025 saw a single-quarter main business revenue of 660 million yuan, a year-on-year increase of 22.96% [3] - The company achieved a gross profit margin of 71.01% and a net profit margin of 21.42% [3] Group 2: Market Position - Dabo Medical's total market capitalization is 24.088 billion yuan, ranking 9th in the medical device industry [3] - The company has a price-to-earnings ratio (P/E) of 49.31, which is lower than the industry average of 67.16 [3] - The return on equity (ROE) stands at 7.6%, significantly higher than the industry average of 1.8% [3] Group 3: Capital Flow - On October 9, 2025, the net inflow of main funds was 22.5649 million yuan, accounting for 5.95% of the total transaction amount [2] - Retail investors experienced a net outflow of 30.9949 million yuan, representing 8.18% of the total transaction amount [2] - Over the past five days, the stock has seen fluctuations in capital flow, with varying net inflows and outflows from different investor categories [2]